Results 91 to 100 of about 168,851 (224)

Aplastic anaemia in a low resource economy: experience and survival of cases at University of Medical Sciences, Ondo, Southwest, Nigeria

open access: yes, 2022
Objective: The objective of the study is to determine the incidence, and discuss management practices currently in use alongside survival outcome at the University of Medical Sciences Teaching Hospital (UNIMEDTH), Ondo State, Nigeria over a 10-year ...
Ojo, M.   +4 more
core  

Table1_Immune checkpoint inhibitor-induced aplastic anaemia: Case series and large-scale pharmacovigilance analysis.DOCX

open access: yes, 2023
Introduction: Impressive advances in immunotherapy especially immune checkpoint inhibitors have made great progress in treating multiple cancers but can also cause serious even incurable immune-related adverse events, mostly found in colitis, dermatitis,
Qian Guo (107009)   +5 more
core   +1 more source

How I manage aplastic anaemia in children

open access: yes
Aplastic anaemia (AA) is a rare heterogeneous condition in children. 1520% of cases are constitutional and correct diagnosis of these inherited causes of AA is important for appropriate management.
Samarasinghe S, Webb DKH
core   +2 more sources

Spectrum of Pancytopenia in Local Population

open access: yesPakistan Armed Forces Medical Journal
Objective: To determine the frequency of pancytopenia aetiologies in local population. Study Design: Cross sectional study Place and Duration of Study: Haematology Department, Armed Forces Institute of Pathology, Rawalpindi Pakistan, from Jun 2020 ...
Syeda Samia Shafaat   +3 more
doaj   +1 more source

Oral Lichenoid Lesions in Patients With Dyskeratosis Congenita: A Retrospective Case Series

open access: yesOral Diseases, EarlyView.
ABSTRACT Background Dyskeratosis congenita (DKC) is a rare inherited multisystem disorder primarily affecting the mucocutaneous and hematopoietic systems. Classically, it presents with the ectodermal triad of reticulate skin pigmentation, nail dystrophy, and oral leukoplakia.
Yehuda Zadik   +9 more
wiley   +1 more source

Late onset pancytopenia post chimeric antigen receptor T cell therapy triggered by a COVID-19 vaccination: a case report

open access: yesFrontiers in Hematology
Cytopenia is a common side effect after chimeric antigen receptor T cell (CAR-T) therapy but is unusual at late timepoints when it is most commonly due to bone marrow (BM) failure, myelodysplasia (MDS) or other secondary malignancies. In this case report,
Nicola Maciocia   +10 more
doaj   +1 more source

Understanding extracellular vesicles in antiaging

open access: yesPeriodontology 2000, EarlyView.
Abstract Background Aging is a multifactorial process marked by gradual cellular dysregulation, regulated by hallmarks, including genomic instability, mitochondrial dysregulation, and chronic inflammation. Extracellular vesicles (EVs), especially exosomes, have emerged as pivotal mediators of cell‐to‐cell communication with potential roles in both ...
Paras Ahmad   +3 more
wiley   +1 more source

White cell and platelet component support in human bone marrow transplantation

open access: yesCurationis, 1983
Bone marrow transplantation is the preferred form of treatment for patients with severe acute aplastic anaemia and immunodeficiency disease. The procedure has also been used in the treatment of patients with refractory or relapsed acute leukaemia and may
L. Wood, P. Jacobs
doaj   +1 more source

Challenges of Dengue in Hematological Disease Patients: Descriptive Analysis From the DANGO Registry During the 2023–2024 Outbreak in Argentina

open access: yesTransplant Infectious Disease, EarlyView.
During the 2023–2024 Argentine dengue outbreak, 33 patients with hematological disease showed high complication rates, frequent hospitalization (64%), severe thrombocytopenia (90%), and 6% dengue‐attributable mortality. Transfusion‐associated cases were documented.
Gustavo Adolfo Méndez   +16 more
wiley   +1 more source

Single institution outcomes of treatment of severe aplastic anaemia

open access: yes, 2001
Background: In severe aplastic anaemia, the treatment of choice for young patients with a human leucocyte antigen-matched sibling is now established as allogeneic bone marrow transplantation (BMT). In older patients and in those without a matched sibling
J. Rowell   +13 more
core   +1 more source

Home - About - Disclaimer - Privacy